|
2023 Year In Review
Our annual presentation on the year in biotech presented by Bruce Booth
|
|
The Biotech Startup Contraction Continues…And That's A Good Thing
LifeSciVC post by Bruce Booth
|
|
Has Spring Sprouted New Growth in Immuno-Oncology?
From the Trenches Post by Jonathan Montagu, CEO, HotSpot Therapeutics
|
|
Deconstructing the Diligence Process: An Approach to Vetting New Product Theses
From the Trenches Post by Aimee Raleigh, Principal, Atlas Venture
|
|
Stars and Scars… Some Lessons Learned About Leadership
From the Trenches Post by Arthur Tzianabos, CEO, Lifordi Immunotherapeutics
|
|
|
|
